Total Funding
56
Total FundingNon-equity Assistance raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
198220
Empire Biotechnologies is a therapeutics company developing therapies for diseases with significant unmet medical needs.
About the Company
Empire Biotechnologies is developing an orally delivered, protein therapeutic called Mfge8 to treat diseases of malabsorption. It aims to develop and promote technologies that will bring positive change to the world.
Empire Biotechnologies was formed in 2013 to execute its goal of commercializing platform technologies currently under development
at the SUNY College of Nanoscale Science and Engineering and the University of California San Francisco.
